Compounds > 1-palmitoyl-2-(10-(4-((trifluoromethyl)diazirinyl)phenyl)-8-oxadecanoyl)-sn-glycero-3-phosphocholine
Page last updated: 2024-12-10
1-palmitoyl-2-(10-(4-((trifluoromethyl)diazirinyl)phenyl)-8-oxadecanoyl)-sn-glycero-3-phosphocholine
Description
1-palmitoyl-2-(10-(4-((trifluoromethyl)diazirinyl)phenyl)-8-oxadecanoyl)-sn-glycero-3-phosphocholine, also known as **1-palmitoyl-2-[(10-(4-trifluoromethyldiazirinyl)phenyl)-8-oxadecanoyl]-sn-glycero-3-phosphocholine** or **TriFM-DOPE**, is a **photoactivatable lipid analog**.
Here's a breakdown:
**Components:**
* **1-palmitoyl-2-[(10-(4-trifluoromethyldiazirinyl)phenyl)-8-oxadecanoyl]-sn-glycero-3-phosphocholine:** This is the full chemical name.
* **TriFM-DOPE:** This is a shorter, more commonly used name. It stands for TrifluoroMethyl-Diazirine-Octadecyl-PhosphoEthanolamine.
* **sn-glycero-3-phosphocholine:** This is the core structure of a phospholipid, a major component of cell membranes.
* **Palmitoyl:** This is a saturated fatty acid chain with 16 carbons.
* **(10-(4-((trifluoromethyl)diazirinyl)phenyl)-8-oxadecanoyl):** This is a modified fatty acid chain containing a diazirine group attached to a phenyl ring.
**Photoactivatable Property:**
* **Diazirine group:** This group is the key to the photoactivation. It is a highly reactive molecule that can be induced to form a **carbene** (a highly reactive species) when exposed to ultraviolet (UV) light.
* **Carbene:** This carbene will then react with and covalently bind to nearby molecules.
**Importance in Research:**
TriFM-DOPE is a valuable tool for studying **protein-lipid interactions** within cell membranes. This is because:
1. **Membrane Incorporation:** It can be incorporated into cell membranes due to its phospholipid structure.
2. **Specific Targeting:** The diazirine group allows for **targeted photolabeling** of proteins that are in close proximity to the lipid.
3. **Identification of Interactions:** After photoactivation, the covalent bond between the carbene and the target protein allows for **identification and analysis of the interacting proteins**.
**Applications in Research:**
* **Membrane protein studies:** TriFM-DOPE has been used to study the interaction of proteins with membrane lipids, revealing information about protein structure, function, and localization within the membrane.
* **Signal transduction research:** It helps understand how lipids are involved in signal transduction pathways and how proteins interact with lipids in these processes.
* **Drug discovery:** TriFM-DOPE can be used to identify potential drug targets that interact with specific lipids in the cell membrane.
**In summary, TriFM-DOPE is a powerful tool for studying protein-lipid interactions, offering valuable insights into cell membrane biology and facilitating research in various fields.**
1-palmitoyl-2-(10-(4-((trifluoromethyl)diazirinyl)phenyl)-8-oxadecanoyl)-sn-glycero-3-phosphocholine: RN given refers to parent cpd; RN given from first source [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]
Cross-References
ID Source | ID |
PubMed CID | 3036276 |
MeSH ID | M0117062 |
Synonyms (8)
Synonym |
3,5,8,16-tetraoxa-4-phosphaoctadecan-17-t-1-aminium, 4-hydroxy-n,n,n-trimethyl-9-oxo-7-(((1-oxohexadecyl)oxy)methyl)-18-(4-(3-(trifluoromethyl)-3h-diazirin-3-yl)phenyl)-, hydroxide, inner salt, 4-oxide |
86013-84-5 |
1-palmitoyl-2-(10-(4-((trifluoromethyl)diazirinyl)phenyl)-8-oxadecanoyl)-sn-glycero-3-phosphocholine |
ptpc |
[3-hexadecanoyloxy-2-[7-[2-[4-[3-(trifluoromethyl)diazirin-3-yl]phenyl]-1-tritioethoxy]heptanoyloxy]propyl] 2-(trimethylazaniumyl)ethyl phosphate |
DTXSID701006587 |
3-(hexadecanoyloxy)-2-[(7-{[2-{4-[3-(trifluoromethyl)-3h-diaziren-3-yl]phenyl}(1-~3~h_1_)ethyl]oxy}heptanoyl)oxy]propyl 2-(trimethylazaniumyl)ethyl phosphate |
govklkklymxkns-zcsgcdbxsa-n |
Research
Studies (6)
Timeframe | Studies, This Drug (%) | All Drugs % |
pre-1990 | 2 (33.33) | 18.7374 |
1990's | 1 (16.67) | 18.2507 |
2000's | 3 (50.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |
Market Indicators
Research Demand Index: 12.67
According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.
Metric | This Compound (vs All) |
---|
Research Demand Index | 12.67 (24.57) | Research Supply Index | 1.95 (2.92) | Research Growth Index | 4.62 (4.65) | Search Engine Demand Index | 0.00 (26.88) | Search Engine Supply Index | 0.00 (0.95) |
| |
Study Types
Publication Type | This drug (%) | All Drugs (%) |
Trials | 0 (0.00%) | 5.53% |
Reviews | 0 (0.00%) | 6.00% |
Case Studies | 0 (0.00%) | 4.05% |
Observational | 0 (0.00%) | 0.25% |
Other | 6 (100.00%) | 84.16% |
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |